This is new info...
"In addition to generating successful neutralizing antibody responses without any non-neutralizing antibodies ex-vivo, our vaccine has so far exceeded our own expectations, lacking the induction of any counterproductive Th2 responses and IL-5. Th2 antibody and IL-5 responses have been reported in multisystem inflammatory syndrome patients and other patients who have had severe responses to SARS-CoV-2. As we await results on further lab tests, we now increasingly expect that this vaccine may be the only, or one of the only, vaccines in development that is able to meet the highest standards of generating neutralizing antibodies without non-neutralizing antibodies, not generating Th2 responses, and not generating IL-5 production. A vaccine able to accomplish the aforementioned standards will likely have a superior efficacy and safety profile. Such a vaccine will likely be critical for the general population’s well-being and highly valuable in the marketplace."